Vericel Corp. Stock
Your prediction
Vericel Corp. Stock
There is an upward development for Vericel Corp. compared to yesterday, with an increase of €0.60 (1.480%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vericel Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vericel Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vericel Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vericel Corp. | 1.480% | 4.569% | 6.186% | 16.384% | 30.380% | 20.468% | -5.505% |
| Pacira Pharmaceuticals | 2.630% | 3.540% | 5.405% | 25.134% | 8.333% | -28.221% | -52.439% |
| Supernus Pharmaceuticals | -2.960% | -4.369% | -2.956% | 35.862% | -8.372% | 42.754% | 79.091% |
| Collegium Pharmaceutical Inc | -0.640% | 0.645% | -1.266% | 18.182% | -24.638% | 57.576% | 51.456% |
Comments
News
Vericel Q2 Earnings Call Highlights
Key Points
- Interested in Vericel Corporation? Here are five stocks we like better.
- Record Q2 performance: Vericel’s revenue rose 22% year over year to $77.5 million, while GAAP net income
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests
Michael Halpin, Chief Operating Officer of Vericel Corporation (NASDAQ:VCEL), reported the sale of 10,000 shares of Common Stock for a transaction value of approximately $402,000 on June 18, 2026
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Soleus Capital Management disclosed a significant buy of Vericel (NASDAQ:VCEL), adding 1,785,079 shares in the first quarter—an estimated $63.40 million trade based on quarterly average